Allist(SH:688578) Xin Lang Cai Jing·2025-10-27 02:31Group 1 - The core viewpoint of the news is that Ailis Pharmaceutical has seen a stock price increase of 5.04%, reaching 112.45 CNY per share, with a total market capitalization of 50.602 billion CNY [1] - Ailis Pharmaceutical, established on March 22, 2004, focuses on the research, production, and sales of innovative drugs, with 99.93% of its revenue coming from drug sales [1] - The trading volume for Ailis Pharmaceutical was 327 million CNY, with a turnover rate of 0.66% [1] Group 2 - According to fund holdings, Wan Jia Fund has a significant position in Ailis, with its Wan Jia Medical Quantitative Selection Mixed Fund A holding 2,800 shares, representing 1.96% of the fund's net value [2] - The fund has achieved a year-to-date return of 26.75% and a one-year return of 27.14%, ranking 3480 out of 8226 and 3178 out of 8099 respectively [2] - The fund manager, Yin Hang, has a tenure of 5 years and 100 days, with the best fund return during this period being 66.32% [2]